See more : Alimco Financial Corporation (ALMC) Income Statement Analysis – Financial Results
Complete financial analysis of Core Scientific, Inc. (CORZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Scientific, Inc., a leading company in the Software – Infrastructure industry within the Technology sector.
- América Móvil, S.A.B. de C.V. (AMOVF) Income Statement Analysis – Financial Results
- Sunraj Diamond Exports Limited (SUNRAJDI.BO) Income Statement Analysis – Financial Results
- Iris Acquisition Corp (IRAA) Income Statement Analysis – Financial Results
- Goldlok Holdings(Guangdong) Co.,Ltd. (002348.SZ) Income Statement Analysis – Financial Results
- Aimfinity Investment Corp. I (AIMAU) Income Statement Analysis – Financial Results
Core Scientific, Inc. (CORZ)
About Core Scientific, Inc.
Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services. The company mines digital assets for its own account and provides hosting colocation services for other large-scale miners. It operates in two segments, Equipment Sales and Hosting. The company owns and operates computer equipment that is used to process transactions conducted on one or more blockchain networks in exchange for transaction processing fees rewarded in digital currency assets, commonly referred to as mining; and datacenter facilities to provide colocation and hosting services for distributed ledger technology, also commonly known as blockchain. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. The company is headquartered in Austin, Texas. On December 21, 2022, Core Scientific, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 502.40M | 640.31M | 544.48M | 60.32M | 59.52M |
| Cost of Revenue | 378.94M | 631.91M | 305.62M | 50.93M | 49.00M |
| Gross Profit | 123.46M | 8.40M | 238.86M | 9.39M | 10.53M |
| Gross Profit Ratio | 24.57% | 1.31% | 43.87% | 15.57% | 17.69% |
| Research & Development | 7.18M | 26.96M | 7.67M | 5.27M | 5.48M |
| General & Administrative | 93.91M | 213.28M | 60.49M | 14.55M | 13.78M |
| Selling & Marketing | 7.02M | 12.73M | 4.06M | 1.77M | 2.83M |
| SG&A | 100.93M | 226.01M | 64.55M | 10.40K | 16.61M |
| Other Expenses | 0.00 | -192.09M | -16.05M | -110.00K | 0.00 |
| Operating Expenses | 108.11M | 252.97M | 72.22M | 10.40K | 22.21M |
| Cost & Expenses | 487.05M | 884.89M | 377.84M | 10.40K | 71.21M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 235.00K |
| Interest Expense | 86.24M | 96.83M | 44.35M | 4.44M | 235.00K |
| Depreciation & Amortization | 96.45M | 226.09M | 33.36M | 9.40M | 6.12M |
| EBITDA | -63.12M | -1.84B | 167.61M | -10.40K | -4.64M |
| EBITDA Ratio | -12.56% | -2.89% | 36.73% | -0.02% | -7.79% |
| Operating Income | 8.96M | -244.57M | 166.64M | -10.40K | -10.76M |
| Operating Income Ratio | 1.78% | -38.20% | 30.61% | -0.02% | -18.07% |
| Total Other Income/Expenses | -254.77M | -53.86M | -68.42M | -5.88M | -235.00K |
| Income Before Tax | -245.80M | -2.16B | 63.08M | -10.40K | -11.92M |
| Income Before Tax Ratio | -48.93% | -337.87% | 11.58% | -0.02% | -20.03% |
| Income Tax Expense | 683.00K | -17.09M | 15.76M | -4.97M | 0.00 |
| Net Income | -246.49M | -2.15B | 47.31M | -10.40K | -11.92M |
| Net Income Ratio | -49.06% | -335.20% | 8.69% | -0.02% | -20.03% |
| EPS | -0.65 | -6.30 | 0.23 | 0.00 | -0.12 |
| EPS Diluted | -0.65 | -6.30 | 0.20 | 0.00 | -0.12 |
| Weighted Avg Shares Out | 379.86M | 340.65M | 207.26M | 43.13M | 98.68M |
| Weighted Avg Shares Out (Dil) | 379.86M | 340.65M | 233.31M | 43.13M | 98.68M |
Core Scientific Prices Upsized $400 Million Convertible Senior Notes Offering
Core Scientific, Inc. to Participate in the 44th Annual Cannacord Genuity Growth Conference
Core Scientific: Deserves Better As HPC Moves Into High Gear
Core Scientific, Inc. (CORZ) Q2 2024 Earnings Call Transcript
Wall Street Analysts Think Core Scientific, Inc. (CORZ) Could Surge 51.49%: Read This Before Placing a Bet
Bitcoin miner Core Scientific rides AI from bankruptcy to $6.7 billion partnership in eight months
Core Scientific Announces Exercise of Additional Contract Option by CoreWeave for Delivery of Approximately 112 MW of Additional Infrastructure to Host High-Performance Computing Operations
Core Scientific Announces July 2024 Production and Operations Updates
Cantor Fitzgerald sets $20 price target for Core Scientific stock: Should you buy?
Core Scientific Analyst Emphasizes 'Access To Power' In Bitcoin Mining Assets - Deal With CoreWeave Under Focus
Source: https://incomestatements.info
Category: Stock Reports